{
  "zip": "VG1110",
  "sector": "Healthcare",
  "longBusinessSummary": "Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.",
  "city": "Tortola",
  "phone": "416 929 1806",
  "country": "British Virgin Islands",
  "companyOfficers": [],
  "website": "http://www.portagebiotech.com",
  "maxAge": 1,
  "address1": "Craigmuir Chambers",
  "industry": "Biotechnology",
  "address2": "Road Town",
  "previousClose": 18.3965,
  "regularMarketOpen": 19.49,
  "twoHundredDayAverage": 18.0645,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 19.5,
  "navPrice": null,
  "averageDailyVolume10Day": 6700,
  "totalAssets": null,
  "regularMarketPreviousClose": 18.3965,
  "fiftyDayAverage": 18.0645,
  "trailingAnnualDividendRate": null,
  "open": 19.49,
  "averageVolume10days": 6700,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 143.52731,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 18.2515,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 5930,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 242622448,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 6700,
  "priceToSalesTrailing12Months": null,
  "dayLow": 18.2515,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 5930,
  "fiftyTwoWeekHigh": 19.51,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 17.492,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 19.5,
  "exchange": "PNK",
  "shortName": "PORTAGE BIOTECH INC",
  "longName": "Portage Biotech Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "PTGEF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_233586353",
  "uuid": "97af78b3-b6c0-39c1-84a3-396b8a9420fb",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 12083400,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 8.748,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1585612800,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -5769000,
  "trailingEps": -0.518,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 2.2235367,
  "heldPercentInsiders": 0.63251,
  "nextFiscalYearEnd": 1648684800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 4446931,
  "enterpriseValue": 277904160,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1591228800,
  "lastSplitFactor": "1:100",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 19.49,
  "logo_url": "https://logo.clearbit.com/portagebiotech.com"
}